SIMPOSIO CONGIUNTOCARDIOLOGIST 4.0: INTEGRATING AI INTO CLINICAL EXCELLENCE (S 2690) Venerdì 8 Maggio | 17.00 – 18.00 | Sala del Tempio 2 Moderatori: Simona Giubilato (Catania) – Stacey E. Rosen 17.00Personalised Medicine in Cardiac Diseases through AIPietro Bonizzi (Maastricht) 17.15ECG

SIMPOSIOAI IN CARDIOLOGY: THE LIVING FUTURE (S 2423) Sabato 9 Maggio | 12.00 – 13.30 | Sala del Tempio 1 Moderatori: Andrea Di Lenarda (Trieste) – Simona Giubilato (Catania) 12.00Artificial Intelligence in Cardiology: Algorithms and Clinical ApplicationsJulia Ramirez (Spain) 12.15Synthetic

SIMPOSIO CONGIUNTOSUDDEN CARDIAC ARREST – FROM INHERITED SYNDROMES TO COMMUNITY STRATEGIES (S 2422) Sudden cardiac arrest remains one of the leading causes of mortality worldwide and requires a comprehensive strategy that spans from genetic and electrophysiological mechanisms to population-based prevention

SIMPOSIOPIONEERS AND PROGRESS: LANDMARK ADVANCES IN CARDIAC ARRHYTHMIA MANAGEMENT (S 2421) Cardiac arrhythmia management is entering a new era in which technological innovation, mechanistic understanding, and precision-based therapies are converging to reshape clinical practice. This session is designed to highlight

SIMPOSIO CONGIUNTOSTARDUST ON CARDIO-ONCOLOGY: A JOURNEY THROUGH THE DREAMS OF FEDERICO (S 2420) Cardio-oncology is almost a newborn, yet it is growing fast. Like every child, dreams and reality are intertwined, and it is often dreams that push us forward.We

SIMPOSIO CONGIUNTO PATIENT-TAILORED CARDIOVASCULAR PREVENTION (S 2419) Advances in cardiovascular science have highlighted the heterogeneity of cardiovascular risk, driven by genetic predisposition, comorbidities, lifestyle, and life-stage–related physiological changes. Novel biomarkers and improved imaging techniques now enable more refined risk assessment,

SIMPOSIOHIGHLIGHTS AND FUTURE PERSPECTIVES IN CARDIOVASCULAR IMAGING (S 2418) Venerdì 8 Maggio | 12.30 – 13.30 | Sala del Tempio 1 Moderatori: Benedetta Carla De Chiara (Milano) – Vered Gil Ad (Genova) 12.30EchocardiographyAgoston Gergely (Szeged) 12.42Magnetic resonanceChiara Bucciarelli-ducci (Bristol) 12.54AI

SIMPOSIOPREGNANCY (S 2417) The latest guidelines (GL) published by the ESC in 2025 have highlighted several key concepts in the management of pregnancy in relation to cardiovascular diseases, foremost among them the need for a dedicated multidisciplinary team, active from

SIMPOSIOHYPERTROPHIC CARDIOMYOPATHY TODAY: ADVANCES IN DIAGNOSIS, RISK STRATIFICATION, AND TREATMENT (S 2416) Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease and a leading cause of sudden cardiac death in young individuals and athletes. Over the last decade, major

SIMPOSIO CONGIUNTORESHAPING LIPID MANAGEMENT IN THE POST-STATIN ERA (S 2415) The scientific session “Reshaping Lipid Management in the Post-Statin Era” focuses on moving beyond sole reliance on statins for atherosclerotic cardiovascular disease risk reduction. The session addresses the need to